NOTCH1 and breast cancer: Previous research has demonstrated that the loss of OPA interacting protein 5 can inhibit BC proliferation via the hsa-miR-139-5p/NOTCH1 axis (81), and hsa-miR-7-5p has also been implicated in BC progression (82).